Abstract
Common as well as unusual, heretofore unmentioned histopathologic features observed in 336 typical and 273 atypical medullary breast cancers from 6404 patients enrolled in various stage I and II protocols of the National Surgical Adjuvant Breast and Bowel Projects (NSABP) are presented. Both medullary types exhibited comparable pathologic findings, except for the infiltrative border and/or slight or absent tumor lymphoid infiltrate which by definition characterize the atypical form. Both also demonstrated a similar, high proclivity to be aneuploid, and to lack estrogen and progesterone receptors and nodal metastases. After appropriate statistical adjustments, survival (analyzed for 198 patients with typical and 149 with atypical medullary cancers) was found to be better for untreated, node-negative and node-positive patients treated with L-PAM + 5 Fu who had typical medullary cancers than those with the NOS histologic type. The magnitude of this difference was 6% at 5 and 17% at 10 years post-operatively (cumulative odds = 1.81 with a 95% confidence interval of 1.08 – 3.3) for the former group, and 4% at 5 and 16% at 10 years (cumulative odds = 1.56 with a 95% confidence interval of 1.08 – 2.23) for the latter. Survival was comparable for patients with atypical medullary and NOS types in both situations. No clear difference in survival was found in untreated, positive node patients with the 3 histologic types examined, although the sample sizes in this subset were relatively small. This information as well as other pertinent considerations indicate that the prognosis of typical medullary cancer is not as ‘good’ as previously perceived. It is also concluded that there is insufficient evidence at present to exclude the atypical medullary variant as a histologic type of breast cancer.
References
Rapin V, Contesso G, Mouriesse H, Bertin F, Lacombe MJ, Piekarski JD, Travaggi JP, Gadenne C, Friedman S: Medullary breast carcinoma: A re-evaluation of 95 cases of breast cancer with inflammatory stroma. Cancer 61: 2503–2510, 1988
Wargotz ES, Silverberg SG: Medullary carcinoma of the breast: A clinicopathologic study with appraisal of current diagnostic criteria. Human Path 19: 1340–1346, 1988
Pedersen L, Holck S, Schiodt T, Zedeler K, Mouridsen HT: Inter- and intraobserver variability in the histopathological diagnosis of medullary cardinoma of the breast, and its prognostic implications. Breast Cancer Res Treat 14: 91–99, 1989
Pedersen L, Holck S, Schiodt T: Medullary carcinoma of breast. Cancer Treat Rev 15: 53–63, 1988
Moore OS Jr, Foote FW Jr: The relatively favorable prognosis of medullary carcinoma of the breast. Cancer 2: 635–642, 1949
Richardson WW: Medullary carcinoma of the breast. Br J Cancer 10: 415–426, 1956
Bloom HJG, Richardson WW, Field JR: Host resistance and survival in carcinoma of breast: A study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years. Br Med J 3: 181–188, 1970
Schiodt T: Breast Carcinoma. Munksgaard, Copenhagen, 1966
Schwartz GF: Solid circumscribed carcinoma of the breast. Ann Surg 169: 165–173, 1969
Haagensen CC: Diseases of the Breast, 2nd ed. WB Saunders, Philadephia, 1973
Flores L, Arlen M, Elguezabal A, Livingston SF, Levowitz BS: Surg Gynecol Obstet 139: 683–688, 1974
Maier WP, Rosemond GP, Goldman LI, Kaplan GF, Tyson RR: A ten year study of medullary carcinoma of breast. Surg Gynecol Obstet 144: 695–698, 1977
Black CL, Morris DM, Goldman LI, McDonald JC: The significance of lymph node involvement in patients with medullary carcinoma of the breast. Surg Gynecol Obstet 157: 497–499, 1983
Fisher ER, Gregorio RM, Fisher B: The pathology of invasive breast cancer: A syllabus derived from findings of the National Surgical Adjuvant Breast Project (Protocol No. 4). Cancer 36: 1–84, 1975
Fisher ER, Gregorio RM, Redmond C, Dekker A, Fisher B: Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). II. The significance of the regional node histology other than sinus histiocytosis in invasive mammary cancer. Am J Clin Path 65: 21–30, 1976
Fisher ER, Redmond C, Fisher B: Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). Discriminants for five-year treatment failure. Cancer 46: 908–918, 1980
Fisher ER, Sass R, Fisher B: Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). X. Discriminants for ten-year treatment failure. Cancer 53: 712–723, 1984
Fisher ER, Sass R, Fisher B: Pathologic findings from the National Surgical Adjuvant Breast Project. Correlations with concordant and discordant estrogen and progesterone receptors. Cancer 59: 1554–1559, 1987
Geschickter CF: Diseases of the Breast: Diagnosis, Pathology, Treatment. JB Lipincott, Philadelphia, 1943
Foote FW Jr, Stewart FW: A histological classification of carcinoma of the breast. Surgery 19: 74–99, 1946
Ridolfi RL, Rosen PP, Port A, Kinne D, Mike V: Medullary carcinoma of breast. Cancer 40: 1365–1385, 1977
Cutler S, Ederer F: Maximization of the life table method in analyzing survival. J Chronic Dis 8: 699–712, 1958
Mantel N, Haenszel W: Statistical aspects of the analysis of data from the retrospective study of disease. JNCI 22: 719–748, 1959
Cox DR: Cox regression models and life tables. J R Stat Soc (B) 34: 187–220, 1972
Hedley D, Friedlander M, Taylor I: Application of DNA flow cytometry to paraffin archival material for study of aneuploidy and clinical significance. Cytometry 6: 327–333, 1985
Azzopardi JG: Problems in Breast Pathology. WB Saunders, Philadelphia, 1979
Horst HA, Horny HP: Frequency distribution of lymphoreticular infiltrates in invasive carcinoma of the female breast. Cancer Detect Prev 11: 297–301, 1988
Fisher ER, Redmond C, Fisher B, Bass G: Pathologic findings from the National Surgical Adjuvant Breast and Bowel Projects (NSABP): Prognostic discriminants for 8 year survival in 950 patients with node negative breast cancer. Cancer (in press)
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Fisher, E.R., Kenny, J.P., Sass, R. et al. Medullary cancer of the breast revisited. Breast Cancer Res Tr 16, 215–229 (1990). https://doi.org/10.1007/BF01806330
Issue Date:
DOI: https://doi.org/10.1007/BF01806330